CALGARY, ALBERTA - March 4, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the commencement of the Frances Creek ...
CALGARY, AB - March 16, 2026 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX-V: VM) (OTC Pink: VYYRF) (the "Company" or "Voyageur"), a pharmaceutical company focused on developing barium and ...
Voyageur Completes Human Testing of Barium Contrast Products and Prepares for Canadian Market Launch
Calgary, Alberta, Canada – April 1, 2025 –TheNewswire -Voyageur Pharmaceuticals Ltd. (VM:CA) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the successful completion of a key ...
What is Double-contrast Barium Enema? Double-contrast barium enema is a radiological technique that can be used to screen individuals for colorectal cancer. It is preferred in individuals who cannot ...
Calgary, Alberta, Canada – April 23, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") a radiology contrast media company focused on vertical ...
Bracco Diagnostics announced that the Food and Drug Administration (FDA) has approved E-Z-HD (barium sulfate) for oral suspension for use in double-contrast radiographic examinations of the esophagus, ...
Is single-contrast barium enema acceptable management for the patient following unsuccessful colonoscopy? Is air contrast better, or should a repeat colonoscopy be planned? The question posed is ...
Voyageur Pharmaceuticals Ltd. (TSX-V: VM) (the "Company" or "Voyageur "), a Canadian developer of pharmaceutical-grad ...
CALGARY, Alberta, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM, USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce the fully-integrated iodine business ...
The foul-tasting barium sulfate liquid that patients have to drink before a CT scan of the digestive system could be replaced by ordinary whole milk, a small study suggests. Barium sulfate is used to ...
Voyageur announced on January 13, 2025 (Testing) that the company commenced testing of its current barium contrast media formulations in human subjects, to ensure efficacy and safety in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results